One early study found IgE receptor antagonists (omalizumab) have not demonstrated efficacy in atopic dermatitis (72), indicating that the development of AD-like skin inflammation was largely dependent on IL-4/13 signaling but not on IgE (73). The gene discussed is IL4; the disease is Alzheimer disease.